{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:15Z","timestamp":1792737675883,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:21:25Z","timestamp":1791969685000},"page":"899-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton Therapy for Breast, Prostate, and Leptomeningeal Disease\u2014Some Answers, but Questions Persist"],"prefix":"10.1016","volume":"126","author":[{"given":"Lakshmi Rekha","family":"Narra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8200-5371","authenticated-orcid":false,"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.08.002_bib0001","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijrobp.2025.08.025","article-title":"Phase III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: A Radiotherapy Comparative Effectiveness (Radcomp) consortium trial: Health-related quality of life outcomes","volume":"123","author":"MacDonald","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025556","article-title":"Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: The Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol","volume":"9","author":"Bekelman","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.08.002_bib0003","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2019.04.015","article-title":"Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy: A single institutional experience","volume":"104","author":"DeCesaris","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.06.3055","article-title":"Associations between cardiac radiation dose-volume metrics and health-related quality of life for patients with breast cancer on the RadComp trial","author":"Wright","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.54894","article-title":"Proton therapy for breast cancer\u2014Is the door shut?","volume":"9","author":"Shah","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0284186X.2021.1986229","article-title":"Proton therapy for early breast cancer patients in the DBCG proton trial: Planning, adaptation, and clinical experience from the first 43 patients","volume":"61","author":"Fuglsang Jensen","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.54888","article-title":"Cost-effectiveness of proton therapy compared with photon therapy in breast cancer","author":"Busschaert","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0008","article-title":"Cardiac risk after heart-sparing breast radiotherapy","author":"Quirk","year":"2026","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0009","article-title":"Cardiac substructure dosimetry and major adverse cardiac events after breast radiation therapy: A 12-year cohort study with normal tissue complication probability modeling","author":"Lui","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0010","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/cncr.32938","article-title":"Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy","volume":"126","author":"Xiang","year":"2020","journal-title":"Cancer"},{"issue":"17_suppl","key":"10.1016\/j.ijrobp.2026.08.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2026.44.17_suppl.LBA5012","article-title":"Early results of COMPPARE, a prospective comparison of outcomes with proton and photon radiation in prostate cancer","volume":"44","author":"Mendenhall","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0012","unstructured":"Pragmatic Randomized Trial of Proton vs. photon therapy for patients with non-metastatic breast cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) consortium trial. ClinicalTrials.gov identifier: NCT02603341. Updated November 6, 2025. Accessed Aug 1, 2026. https:\/\/clinicaltrials.gov\/study\/NCT02603341"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0013","unstructured":"ASCO 2026: Early results of COMPPARE, a prospective comparison of outcomes with proton and photon radiation in prostate cancer. Presented at: The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting; May 29 to June 1, 2026; Chicago, IL. Accessed Aug 1, 2026. https:\/\/www.urotoday.com\/conference-highlights\/asco-2026\/asco-2026-prostate-cancer\/169534-asco-2026-lba5012-early-results-of-comppare-a-prospective-comparison-of-outcomes-with-proton-and-photon-radiation-in-prostate-cancer.html"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0014","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/cncr.29148","article-title":"A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer","volume":"121","author":"Fang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0015","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0016","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2024.08.012","article-title":"Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III randomized clinical trial of proton therapy vs. IMRT for localized prostate cancer","volume":"120","author":"Efstathiou","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0017","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41391-019-0140-7","article-title":"Proton versus photon-based radiation therapy for prostate cancer: Emerging evidence and considerations in the era of value-based cancer care","volume":"22","author":"Kamran","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0018","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1470-2045(23)00184-5","article-title":"Global democratisation of proton radiotherapy","volume":"24","author":"Yan","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0019","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2014.01.039","article-title":"In search of the economic sustainability of hadron therapy: The real cost of setting up and operating a hadron facility","volume":"89","author":"Vanderstraeten","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jamaoncol.2025.3007","article-title":"Proton craniospinal irradiation for patients with leptomeningeal metastasis: A randomized clinical trial","volume":"11","author":"Yang","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0021","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/neuonc\/noz024","article-title":"The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: Lack of feasibility and clinical utility and a revised proposal","volume":"21","author":"Le Rhun","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0022","article-title":"Early outcomes from proton craniospinal irradiation for leptomeningeal metastasis from solid tumors","volume":"10","author":"Lam","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0023","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/cancers17061046","article-title":"Proton craniospinal irradiation for patients with solid tumor leptomeningeal disease: Real-world feasibility, toxicity, and outcome analysis","volume":"17","author":"Gal","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0024","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2025.08.002","article-title":"Leptomeningeal metastasis, an evolving frontier for radiation oncology","volume":"123","author":"Breen","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13014-025-02618-7","article-title":"Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease","volume":"20","author":"Ehret","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0026","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.prro.2025.03.015","article-title":"Real-world experience using proton versus photon craniospinal irradiation for leptomeningeal disease","volume":"15","author":"Frechette","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0027","unstructured":"NCCN guidelines. National Comprehensive Cancer Network. Accessed Aug 1, 2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0028","first-page":"vdab181","article-title":"Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis","volume":"3","author":"Wijetunga","year":"2021","journal-title":"Neurooncol Adv."},{"issue":"16_suppl","key":"10.1016\/j.ijrobp.2026.08.002_bib0029","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2026.44.16_suppl.2026","article-title":"Cerebrospinal fluid biomarker profiling in patients with non\u2013small cell lung cancer and leptomeningeal disease","volume":"44","author":"Jeng","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1158\/1078-0432.CCR-22-2434","article-title":"Dynamic mutational landscape of cerebrospinal fluid circulating tumor DNA and predictors of survival after proton craniospinal irradiation for leptomeningeal metastases","volume":"29","author":"Wijetunga","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0031","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11060-024-04615-4","article-title":"Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors","volume":"167","author":"Barbour","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0032","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-022-03949-1","article-title":"Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases","volume":"157","author":"Diaz","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0033","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11060-020-03555-z","article-title":"Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer","volume":"148","author":"Malani","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0034","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.ijrobp.2025.07.1305","article-title":"Toxicity and clinical outcomes of proton vs. photon volumetric modulated arc therapy craniospinal Irradiation for Solid tumor leptomeningeal carcinomatosis","volume":"123","author":"Lamanilao","year":"2025","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.002_bib0035","unstructured":"Testing proton craniospinal radiation therapy versus the usual radiation therapy for leptomeningeal metastasis, RADIATE-LM trial. ClinicalTrials.gov identifier: NCT06500481. Updated August 17, 2026. Accessed Aug 1, 2026. https:\/\/clinicaltrials.gov\/study\/NCT06500481"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626041374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626041374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:32:30Z","timestamp":1792737150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626041374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626041374"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Therapy for Breast, Prostate, and Leptomeningeal Disease\u2014Some Answers, but Questions Persist","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}